Manchester Financial Inc Novartis Ag Transaction History

Manchester Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$85.24 - $94.15 $42,108 - $46,510	-494 Closed	0 $0
Q1 2020 Apr 20, 2020	SELL	$70.67 - $99.01 $18,162 - $25,445	-257 Reduced 34.22%	494 $41,000
Q4 2019 Jan 17, 2020	BUY	$84.35 - $95.37 $63,346 - $71,622	751 New	751 $71,000
Q3 2019 Oct 09, 2019	SELL	$85.54 - $94.26 $42,256 - $46,564	-494 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$75.4 - $92.8 $37,247 - $45,843	494 New	494 $45,000

1,433

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.